References
- Diepgen, T L.; Mahler, V. The epidemiology of skin cancer.Br. J. Dermatol. 2002, 146, 1–6. [PUBMED], [INFOTRIEVE], [CSA]
- Rigel, D S. The effect of sunscreen on melanoma risk.Dermatol. Clin. 2002, 20 (4), 601–606. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jemal, A.; Tiwari, R C.; Murray, T.; Ghafoor, A.; Samuels, A.; , et al. Cancer statistics, 2004.CA, Cancer J. Clin. 2004, 54 (1), 8–29. [CSA]
- Howe, H L.; Wingo, P A.; Thun, M J.; Ries, L A.; Rosenberg, H M.; Feigal, E G.; Edwards, B K. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends.J. Natl. Cancer Inst. 2001, 93 (11), 824–842. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Breslow, A. Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma.Ann. Surg. 1975, 182 (5), 572–575. [PUBMED], [INFOTRIEVE], [CSA]
- Cochran, A J. Prediction of outcome for patients with cutaneous melanoma.Pigment Cell Res. 1997, 10 (3), 162–167. [PUBMED], [INFOTRIEVE], [CSA]
- Reintgen, D S.; Cox, E B.; McCarty, K S., Jr.; Vollmer, R T.; Seigler, H F. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma.Ann. Surg. 1983, 198 (3), 379–385. [PUBMED], [INFOTRIEVE], [CSA]
- Balch, C M.; Buzaid, A C.; Soong, S J.; Atkins, M B.; Cascinelli, N.; , et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.J. Clin. Oncol. 2001, 19 (16), 3635–3648. [PUBMED], [INFOTRIEVE], [CSA]
- Cabanas, R M. An approach for the treatment of penile carcinoma.Cancer 1977, 39 (2), 456–466. [PUBMED], [INFOTRIEVE], [CSA]
- Reintgen, D S.; Cox, C.; Slingluff, C L., Jr.; Seigler, H F. Recurrent malignant melanoma: the identification of prognostic factors to predict survival.Ann. Plast. Surg. 1992, 28 (1), 45–49. [PUBMED], [INFOTRIEVE], [CSA]
- Reintgen, D.; Cruse, C W.; Wells, K.; Berman, C.; Fenske, N.; , et al. The orderly progression of melanoma nodal metastases.Ann. Surg. 1994, 220 (6), 759–767. [PUBMED], [INFOTRIEVE], [CSA]
- Morton, D L.; Thompson, J F.; Essner, R.; Elashoff, R.; Stern, S L.; , et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.Ann. Surg. 1999, 230 (4), 453–463. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Thompson, J F.; McCarthy, W H.; Bosch, C M.; O'Brien, C J.; Quinn, M J.; , et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes.Melanoma Res. 1995, 5 (4), 255–260. [PUBMED], [INFOTRIEVE], [CSA]
- Morton, D L.; Wen, D R.; Wong, J H.; Economou, J S.; Cagle, L A.; , et al. Technical details of intraoperative lymphatic mapping for early stage melanoma.Arch. Surg. 1992, 127 (4), 392–399. [PUBMED], [INFOTRIEVE], [CSA]
- Ross, M I.; Reintgen, D.; Balch, C M. Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma.Sem. Surg. Oncol. 1993, 9 (3), 219–223. [CSA]
- Sung, J.; Li, W.; Shivers, S.; Reintgen, D. Molecular analysis in evaluating the sentinel node in malignant melanoma.Ann. Surg. Oncol. 2001, 8 (Suppl. 9), 29S–30S. [PUBMED], [INFOTRIEVE], [CSA]
- Cho, K H.; Hashimoto, K.; Taniguchi, Y.; Pietruk, T.; Zarbo, R J.; An, T. Immunohistochemical study of melanocytic nevus and malignant melanoma with monoclonal antibodies against S-100 subunits.Cancer 1990, 66 (4), 765–771. [PUBMED], [INFOTRIEVE], [CSA]
- Yu, L L.; Flotte, T J.; Tanabe, K K.; Gadd, M A.; Cosimi, A B.; , et al. Detection of microscopic melanoma metastases in sentinel lymph nodes.Cancer 1999, 86 (4), 617–627., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wang, X.; Heller, R.; VanVoorhis, N.; Cruse, C W.; Glass, F.; , et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma.Ann. Surg. 1994, 220 (6), 768–774. [PUBMED], [INFOTRIEVE], [CSA]
- Shivers, S C.; Wang, X.; Li, W.; Joseph, E.; Messina, J.; , et al. Molecular staging of malignant melanoma: correlation with clinical outcome.JAMA 1998, 280 (16), 1410–1415. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bostick, P J.; Morton, D L.; Turner, R R.; Huynh, K T.; Wang, H J.; , et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients.J. Clin. Oncol. 1999, 17 (10), 3238–3244. [PUBMED], [INFOTRIEVE], [CSA]
- Lukowsky, A.; Bellmann, B.; Ringk, A.; Winter, H.; Audring, H.; Fenske, S.; Sterry, W. Detection of melanoma micrometastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction.J. Invest. Dermatol. 1999, 113 (4), 554–559. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bieligk, S C.; Ghossein, R.; Bhattacharya, S.; Coit, D G. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes.Ann. Surg. Oncol. 1999, 6 (3), 232–240. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Blaheta, H J.; Ellwanger, U.; Schittek, B.; Sotlar, K.; MacZey, E.; , et al. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.J. Invest. Dermatol. 2000, 114 (4), 637–642. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Li, W.; Stall, A.; Shivers, S C.; Lin, J.; Haddad, F.; , et al. Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma.Ann. Surg. 2000, 231 (6), 795–803. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Boi, S.; Cristofolini, P.; Togni, R.; Girlando, S.; Camerani, M.; , et al. Detection of nodal micrometastases using immunohistochemistry and PCR in melanoma of the arm and trunk.Melanoma Res. 2002, 12 (2), 147–153. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Riccioni, L.; Farabegoli, P.; Nanni, O.; Morigi, F.; Polverelli, M.; , et al. The sentinel lymph node in melanoma: utilization of molecular biology (RT-PCR) to detect occult metastases.Pathologica 2002, 94 (4), 190–195. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Carson, K F.; Wen, D R.; Li, P X.; Lana, A M.; Bailly, C.; Morton, D L.; Cochran, A J. Nodal nevi and cutaneous melanomas.Am. J. Surg. Pathol. 1996, 20 (7), 834–840. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gutzmer, R.; Kaspari, M.; Brodersen, J P.; Mommert, S.; Volker, B.; , et al. Specificity of tyrosinase and HMB45 PCR in the detection of melanoma metastases in sentinel lymph node biopsies.Histopathology 2002, 41 (6), 510–518. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Russell-Jones, R. The value of reverse transcription-polymerase chain reaction in malignant melanoma.Br. J. Dermatol. 2001, 145 (2), 193–194. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jung, F A.; Buzaid, A C.; Ross, M I.; Woods, K V.; , et al. Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients.J. Clin. Oncol. 1997, 15 (8), 2826–2831. [PUBMED], [INFOTRIEVE], [CSA]
- Kuo, C T.; Hoon, D S.; Takeuchi, H.; Turner, R.; Wang, H J.; Morton, D L.; Taback, B. Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes.J. Clin. Oncol. 2003, 21 (19), 3566–3572. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Takeuchi, H.; Taback, B.; Kuo, C.; Hoon, D S. Clinicopathological utility of molecular staging for melanoma patients undergoing sentinel lymphadenectomy.Ann. Surg. Oncol. 2004, 11 (Suppl. 3), 152S–155S. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Morton, D L.; Hoon, D S.; Cochran, A J.; Turner, R R.; Essner, R.; , et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases.Ann. Surg. 2003, 238 (4), 538–549. [PUBMED], [INFOTRIEVE], [CSA]
- Palmieri, G.; Ascierto, P A.; Cossu, A.; Mozzillo, N.; Motti, M L.; , et al. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay.J. Clin. Oncol. 2001, 19 (5), 1437–1443. [PUBMED], [INFOTRIEVE], [CSA]
- Smith, B.; Selby, P.; Southgate, J.; Pittman, K.; Bradley, C.; Blair, G E. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction.Lancet 1991, 338 (8777), 1227–1229. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Brossart, P.; Keilholz, U.; Willhauck, M.; Scheibenbogen, C.; Mohler, T.; Hunstein, W. Hematogenous spread of malignant melanoma cells in different stages of disease.J. Invest. Dermatol. 1993, 101 (6), 887–889. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Stevens, G L.; Scheer, W D.; Levine, E A. Detection of tyrosinase mRNA from the blood of melanoma patients.Cancer Epidemiol. Biomark. Prev. 1996, 5 (4), 293–296. [CSA]
- Battayani, Z.; Grob, J J.; Xerri, L.; Noe, C.; Zarour, H.; , et al. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma.Arch. Dermatol. 1995, 131 (4), 443–447. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Proebstle, T M.; Jiang, W.; Hogel, J.; Keilholz, U.; Weber, L.; Voit, C. Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors.Br. J. Cancer 2000, 82 (1), 118–123. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mellado, B.; Colomer, D.; Castel, T.; Munoz, M.; Carballo, E.; , et al. Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis.J. Clin. Oncol. 1996, 14 (7), 2091–2097. [PUBMED], [INFOTRIEVE], [CSA]
- Farthmann, B.; Eberle, J.; Krasagakis, K.; Gstottner, M.; Wang, N.; Bisson, S.; Orfanos, C E. RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients.J. Invest. Dermatol. 1998, 110 (3), 263–267. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ghossein, R A.; Coit, D.; Brennan, M.; Zhang, Z F.; Wang, Y.; , et al. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma.Clin. Cancer Res. 1998, 4 (2), 419–428. [PUBMED], [INFOTRIEVE], [CSA]
- Szenajch, J.; Jasinski, B.; Synowiec, A.; Kulik, J.; Chomicka, M.; , et al. Prognostic value of multiple reverse transcription-PCR tyrosinase testing for circulating neoplastic cells in malignant melanoma.Clin. Chem. 2003, 49 (9), 1450–1457. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pittman, K.; Burchill, S.; Smith, B.; Southgate, J.; Joffe, J.; Gore, M.; Selby, P. Reverse transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood.Ann. Oncol. 1996, 7 (3), 297–301. [PUBMED], [INFOTRIEVE], [CSA]
- Palmieri, G.; Pirastu, M.; Strazzullo, M.; Ascierto, P A.; Satriano, S M.; , et al. Clinical significance of PCR-positive mRNA markers in peripheral blood and regional nodes of malignant melanoma patients. Melanoma Cooperative Group.Recent Results Cancer Res. 2001, 158, 200–203. [PUBMED], [INFOTRIEVE], [CSA]
- Blaheta, H J.; Paul, T.; Sotlar, K.; Maczey, E.; Schittek, B.; , et al. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness.Br. J. Dermatol. 2001, 145 (2), 195–202. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hoon, D S.; Wang, Y.; Dale, P S.; Conrad, A J.; Schmid, P.; , et al. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay.J. Clin. Oncol. 1995, 13 (8), 2109–2116. [PUBMED], [INFOTRIEVE], [CSA]
- Hoon, D S.; Bostick, P.; Kuo, C.; Okamoto, T.; Wang, H J.; Elashoff, R.; Morton, D L. Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence.Cancer Res. 2000, 60 (8), 2253–2257. [PUBMED], [INFOTRIEVE], [CSA]
- Palmieri, G.; Strazzullo, M.; Ascierto, P A.; Satriano, S M.; Daponte, A.; Castello, G. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.J. Clin. Oncol. 1999, 17 (1), 304–311. [PUBMED], [INFOTRIEVE], [CSA]
- Cheung, I Y.; Cheung, N K.; Ghossein, R A.; Satagopan, J M.; Bhattacharya, S.; Coit, D G. Association between molecular detection of GAGE and survival in patients with malignant melanoma: a retrospective cohort study.Clin. Cancer Res. 1999, 5 (8), 2042–2047., [PUBMED], [INFOTRIEVE], [CSA]
- Banfalvi, T.; Boldizsar, M.; Gergye, M.; Gilde, K.; Kremmer, T.; Otto, S. Comparison of prognostic significance of serum 5-S-Cysteinyldopa, LDH and S-100B protein in stage III–IV malignant melanoma.Pathol. Oncol. Res. 2002, 8 (3), 183–187. [PUBMED], [INFOTRIEVE], [CSA]
- Takeuchi, H.; Kuo, C.; Morton, D L.; Wang, H J.; Hoon, D S. Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas.Cancer Res. 2003, 63 (2), 441–448. [PUBMED], [INFOTRIEVE], [CSA]
- Pacifico, M D.; Grover, R.; Richman, P.; Daley, F.; Wilson, G D. Validation of tissue microarray for the immunohistochemical profiling of melanoma.Melanoma Res. 2004, 14 (1), 39–42. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Camp, R L.; Charette, L A.; Rimm, D L. Validation of tissue microarray technology in breast carcinoma.Lab. Invest. 2000, 80 (12), 1943–1949. [PUBMED], [INFOTRIEVE], [CSA]
- Hoos, A.; Urist, M J.; Stojadinovic, A.; Mastorides, S.; Dudas, M E.; , et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors.Am. J. Pathol. 2001, 158 (4), 1245–1251. [PUBMED], [INFOTRIEVE], [CSA]
- Berger, A J.; Kluger, H M.; Li, N.; Kielhorn, E.; Halaban, R.; Ronai, Z.; Rimm, D L. Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival.Cancer Res. 2003, 63 (23), 8103–8107. [PUBMED], [INFOTRIEVE], [CSA]
- Korabiowska, M.; Bauer, H.; Quentin, T.; Stachura, J.; Cordon-Cardo, C.; Brinck, U. Application of new in situ hybridization probes for Ku70 and Ku80 in tissue microarrays of paraffin-embedded malignant melanomas: correlation with immunohistochemical analysis.Human Pathol. 2004, 35 (2), 210–216. [CSA], [CROSSREF]
- von Eggeling, F.; Davies, H.; Lomas, L.; Fiedler, W.; Junker, K.; Claussen, U.; Ernst, G. Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research.Biotechniques 2000, 29 (5), 1066–1070. [PUBMED], [INFOTRIEVE], [CSA]
- Bernard, K.; Litman, E.; Fitzpatrick, J L.; Shellman, Y G.; Argast, G.; , et al. Functional proteomic analysis of melanoma progression.Cancer Res. 2003, 63 (20), 6716–6725. [PUBMED], [INFOTRIEVE], [CSA]
- DeRisi, J.; Penland, L.; Brown, P O.; Bittner, M L.; Meltzer, P S.; , et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer.Nat. Genet. 1996, 14 (4), 457–460. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Baldi, A.; Santini, D.; De Luca, A.; Paggi, M G. cDNA array technology in melanoma: an overview.J. Cell. Physiol. 2003, 196 (2), 219–223. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bittner, M.; Meltzer, P.; Chen, Y.; Jiang, Y.; Seftor, E.; , et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling.Nature 2000, 406 (6795), 536–540. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Seftor, E A.; Meltzer, P S.; Kirschmann, D A.; Pe'er, J.; Maniotis, A J.; , et al. Molecular determinants of human uveal melanoma invasion and metastasis.Clin. Exp. Metastasis 2002, 19 (3), 233–246. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kunz, M.; Koczan, D.; Ibrahim, S M.; Gillitzer, R.; Gross, G.; Thiesen, H J. Differential expression of thrombospondin 2 in primary and metastatic malignant melanoma.Acta Derm.-Venereol. 2002, 82 (3), 163–169. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hoek, K.; Rimm, D.; Williams, K.; Zhao, H.; Ariyan, S.; , et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.Pigment Cell Res. 2004, 17 (4), 430. [CSA], [CROSSREF]
- Roesch, A.; Vogt, T.; Stolz, W.; Dugas, M.; Landthaler, M.; Becker, B. Discrimination between gene expression patterns in the invasive margin and the tumour core of malignant melanomas.Melanoma Res. 2003, 13 (5), 503–509. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McDonald, S L.; Edington, H D.; Kirkwood, J M.; Becker, D. Expression analysis of genes identified by molecular profiling of VGP melanomas and MGP melanoma-positive lymph nodes.Cancer Biol. Ther. 2004, 3 (1), 110–120. [PUBMED], [INFOTRIEVE], [CSA]